Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T18:12:38.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page update only shows a new revision number, changing from v3.4.1 to v3.4.2, with no observable changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:57:29.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 as part of a minor site maintenance; no changes to study data or page content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T22:51:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI changes include a glossary toggle (Show glossary / Hide glossary), a capitalization update for the QC label 'Last Update Submitted that Met QC Criteria', and a capitalization update for the No FEAR Act notice to 'No FEAR Act Data', along with a footer revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-23T17:19:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated from v3.3.3; no visible changes to the study page content or layout.
    Difference
    0.1%
    Check dated 2026-01-16T10:55:31.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a new 'Locations' section with Washington listed as a site, and removed the old 'Washington Locations' header and the 'HHS Vulnerability Disclosure' footer.
    Difference
    0.2%
    Check dated 2025-12-18T21:12:02.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.